Host protein C inhibitor inhibits tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability

Nobuyuki Akita(Suzuka University of Medical Science), Tatsuya Hayashi(Mie University), Kunihiro Asanuma(Mie University), Koji Suzuki(Yokohama City University Medical Center), Ning Ma(Nanjing Forestry University), Motomu Shimaoka(Mie University), Takayuki Okamoto(Mie University), Kakunoshin Yoshida(Mie University), Junji Nishioka(Mie University)
Thrombosis Research
April 11, 2015
10.1016/j.thromres.2015.03.026
Cited by 20

Related Papers

Conformational Regulation of Integrin Structure and Function
|Annual Review of Biophysics and Biomolecular Structure|2002|537
Structures of the αL I Domain and Its Complex with ICAM-1 Reveal a Shape-Shifting Pathway for Integrin Regulation
|Cell|2003|522
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
|The Lancet|2023|514
Therapeutic antagonists and conformational regulation of integrin function
|Nature Reviews Drug Discovery|2003|350
Activation of Leukocyte β2 Integrins by Conversion from Bent to Extended Conformations
|Immunity|2006|256